Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. purchased 6,000 shares of Avalo Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were bought at an average price of $3.48 per share, for a total transaction of $20,880.00. Following the acquisition, the insider now owns 1,417,540 shares in […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 43,800 shares, an increase of 17.1% from the April 30th total of 37,400 shares. Based on an average trading volume of 48,000 shares, the short-interest ratio is […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. bought 7,000 shares of the business’s stock in a transaction on Monday, May 22nd. The stock was bought at an average price of $3.34 per share, for a total transaction of $23,380.00. Following the transaction, the insider now directly owns 1,373,700 shares […]
Avalo Therapeutics (NASDAQ:AVTX – Get Rating) will be issuing its quarterly earnings data on Wednesday, May 3rd. Avalo Therapeutics Price Performance AVTX traded down $0.08 during trading on Tuesday, hitting $3.00. The stock had a trading volume of 7,740 shares, compared to its average volume of 26,211. The company has a 50 day moving average […]
Avalo Therapeutics (NASDAQ:AVTX – Get Rating) is set to issue its quarterly earnings data on Wednesday, May 3rd. Avalo Therapeutics Trading Down 2.6 % Shares of AVTX traded down $0.08 during mid-day trading on Tuesday, hitting $3.00. 7,763 shares of the company’s stock were exchanged, compared to its average volume of 26,212. Avalo Therapeutics has […]